Litcius/Paper detail

Novel combretastatin A-4 derivative containing aminophosphonates as dual inhibitors of tubulin and matrix metalloproteinases for lung cancer treatment

Xiaochao Huang, Yuanhang Chen, Wentian Zhong, Zhikun Liu, Haijiang Zhang, Bin Zhang, Heng‐Shan Wang

2022European Journal of Medicinal Chemistry17 citationsDOIOpen Access PDF

Topics & Concepts

ChemistryApoptosisA549 cellMatrix metalloproteinaseTubulinPharmacologyCancer cellIn vivoCancer researchCytotoxic T cellBiochemistryIn vitroMicrotubuleCancerCell biologyBiologyGeneticsBiotechnologyOrganophosphorus compounds synthesisSynthesis and biological activityPI3K/AKT/mTOR signaling in cancer
Novel combretastatin A-4 derivative containing aminophosphonates as dual inhibitors of tubulin and matrix metalloproteinases for lung cancer treatment | Litcius